Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H0YZ
|
|||
| Former ID |
DIB015158
|
|||
| Drug Name |
GGF-2
|
|||
| Synonyms |
Glial growth factor 2, Cambridge Neuroscience; RhGGF2, Cambridge Neuroscience; GGF-2, CeNeS; GGF-2 (cardiac failure/neurodegenerative disorders); GGF-2 (cardiac failure/neurodegenerative disorders), Acorda
Click to Show/Hide
|
|||
| Indication | Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Phase 1 | [1] | |
| Company |
Acorda therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01258387) Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure. U.S. National Institutes of Health. | |||
| REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.